Flynn Pharma has commissioned the PCWHF to distribute an online survey of our UK primary care members to assess the current challenges in the diagnosis and management of vulvovaginal atrophy (VVA) in post-menopausal women. We would be grateful if you would please set aside 5 minutes to respond to this survey. The result of the survey will be available on request by contacting Flynn via Medinfo@flynnpharma.com and will be published in collaboration with the PCWHF.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.